Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan
Clinical trial NCT03348046 · COMPLETED
Trial details
- NCT number
- NCT03348046
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-23
- Primary completion
- 2019-04-14
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.